Supplemental material
Original Research
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years
, 
, , , , & show all
Lilian Arnauda Ares Trading SA, An Affiliate of Merck KGaA, Eysins, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0003-3028-0253View further author information
https://orcid.org/0000-0003-3028-0253View further author information, , Matthew Keisera Ares Trading SA, An Affiliate of Merck KGaA, Eysins, Switzerlandhttps://orcid.org/0000-0001-6870-6585View further author information
https://orcid.org/0000-0001-6870-6585View further author information, Andrea Seitzingerc Global Biostatistics, Merck Healthcare KGaA, Darmstadt, Germanyhttps://orcid.org/0000-0001-8088-9695View further author information
https://orcid.org/0000-0001-8088-9695View further author information, Dominic Jackd Merck Serono Ltd, An Affiliate of Merck KGaA, Feltham, UKhttps://orcid.org/0000-0001-8629-553XView further author information
https://orcid.org/0000-0001-8629-553XView further author information & Quentin Le Masnee Connected Health and Devices unit, Merck Santé S.A.S. an Affiliate of Merck KGaA, Lyon, Francehttps://orcid.org/0000-0001-7120-130XView further author information
https://orcid.org/0000-0001-7120-130XView further author information show all